End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals segment led the reflux testing devices market, accounting for 49.82% of the market share in 2026. Hospitals remain the primary setting for reflux diagnosis because they offer comprehensive diagnostic capabilities, specialized gastroenterology departments, and access to multidisciplinary clinical expertise. Their ability to manage complex patient cases and provide integrated diagnostic and treatment services continues to support their dominant position in the market.

Ambulatory surgical centers are expected to record the fastest growth as healthcare systems increasingly prioritize efficient outpatient care. These facilities provide convenient access to diagnostic and minimally invasive procedures while reducing hospital stays and overall treatment costs. Rising patient preference for faster, more accessible healthcare services and the expansion of outpatient specialty care continue to strengthen demand within this segment.

Application Segment Analysis: Gastroesophageal Reflux Disease (Largest Segment) vs Surgical Procedures (Fastest-Growing Segment)

In the reflux testing devices market, the gastroesophageal reflux disease application represented the largest segment in 2026. The high prevalence of reflux-related symptoms and the growing emphasis on accurate diagnosis before initiating long-term treatment have supported consistent demand for specialized testing devices. Increasing clinical awareness of disease management and the need for precise diagnostic evaluation further reinforce the segment's leading position.

The surgical procedures application is anticipated to expand at the fastest pace as physicians increasingly rely on detailed reflux assessment before and after anti-reflux interventions. Accurate physiological measurements help optimize patient selection, improve procedural planning, and evaluate treatment outcomes, contributing to broader adoption of reflux testing technologies within surgical care pathways.

Product Type Segment Analysis: Reflux Capsule (Largest Segment) vs Reflux Probe (Fastest-Growing Segment)

Reflux capsules held the largest product type share in 2026, supported by their ability to provide patient-friendly and extended monitoring with minimal disruption to daily activities. Their wireless design improves patient comfort while enabling reliable diagnostic data collection, making them a preferred option for reflux evaluation in many clinical settings.

Within the reflux testing devices market, reflux probes are projected to experience the fastest growth as technological improvements enhance measurement accuracy and expand their use in comprehensive diagnostic assessments. Continued demand for precise physiological monitoring and broader adoption of advanced diagnostic procedures are expected to support increasing utilization of reflux probes across healthcare facilities.